Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dentsply's Degussa Dental Purchase Small Enough To Avoid FTC Challenge

This article was originally published in The Gray Sheet

Executive Summary

Dentsply International's acquisition of Degussa Dental for about $500 mil. in cash will combine the first and second largest suppliers in the worldwide professional dental products market, but the deal is small enough to elude antitrust scrutiny, Dentsply says.

You may also be interested in...

Sulzer Buys Paragon Anticipating Increased Conversion To Dental Implants

Anticipating increased conversion of the tooth replacement market to dental implants from conventional treatments such as bridges and crowns, Sulzer Medica is paying about 3.3 times sales to acquire dental implant maker Core Vent Corporation/Paragon Implant Company. The move roughly doubles Sulzer's share of the $550 mil. dental implant market to about 10.5%.

Dentsply Distribution Practices Violate Antitrust Laws, Justice Says

Dentsply's distribution policies for its Trubyte line of artifical teeth violate U.S. antitrust laws, the Justice Department maintains in a complaint filed Jan. 5 in Delaware federal court.

Generic Oncology Drugs’ Safety Is Key Focus In US FDA Label Updates

US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts